@iobiotech.com
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
IO Biotech is a groundbreaking brand that aims to revolutionize cancer treatment through their innovative T-win® technology. As a pioneer in the field, IO Biotech is developing the first dual-action immune-modulating cancer vaccine that has the potential to become the foundation of combination therapy for individuals with cancer. The T-win® technology is designed to activate and expand T cells, which play a crucial role in fighting cancer, by modulating the tumor microenvironment.
By harnessing the power of the immune system, IO Biotech aims to break new boundaries and ignite change in the way cancer is treated. IO Biotech offers a range of products and services, including participation in clinical trials for those interested. Their mission is to establish the T-win® immune-modulating cancer vaccine as the backbone of combination therapy for individuals with cancer.
With a dedicated team of experts and a commitment to scientific excellence, IO Biotech is at the forefront of transforming cancer treatment and improving patient outcomes. Contact IO Biotech today to learn more about their groundbreaking work in the fight against cancer
Company Type
Public Company
Company Size
51-200
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online